These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 24630733)

  • 1. Strong correlation between glycaemic variability and total glucose exposure in type 2 diabetes is limited to subjects with satisfactory glycaemic control.
    Suh S; Joung JY; Jin SM; Kim MY; Bae JC; Park HD; Lee MS; Lee MK; Kim JH
    Diabetes Metab; 2014 Sep; 40(4):272-7. PubMed ID: 24630733
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Do glycoalbumin levels preferentially reflect changes in postprandial glucose excursions?
    Paul SK; Holman RR
    Diabet Med; 2017 Sep; 34(9):1284-1290. PubMed ID: 28477414
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of markers of glycaemic control in diabetic patients with chronic kidney disease using continuous glucose monitoring.
    Vos FE; Schollum JB; Coulter CV; Manning PJ; Duffull SB; Walker RJ
    Nephrology (Carlton); 2012 Feb; 17(2):182-8. PubMed ID: 21883672
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of complementary markers in assessing glycaemic control in people with diabetic kidney disease undergoing iron or erythropoietin treatment.
    Konya J; Ng JM; Cox H; Cooke M; Lewis N; Bhandari S; Atkin SL; Kilpatrick ES
    Diabet Med; 2013 Oct; 30(10):1250-4. PubMed ID: 23758176
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation between 1,5-anhydroglucitol and glycemic excursions in type 2 diabetic patients.
    Sun J; Dou JT; Wang XL; Yang GQ; Lü ZH; Zheng H; Ma FL; Lu JM; Mu YM
    Chin Med J (Engl); 2011 Nov; 124(22):3641-5. PubMed ID: 22340217
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alternate glycemic markers reflect glycemic variability in continuous glucose monitoring in youth with prediabetes and type 2 diabetes.
    Chan CL; Pyle L; Kelsey MM; Newnes L; Baumgartner A; Zeitler PS; Nadeau KJ
    Pediatr Diabetes; 2017 Nov; 18(7):629-636. PubMed ID: 27873436
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of insulin initiation on glycaemic variability and glucose profiles in a primary healthcare Type 2 diabetes cohort: analysis of continuous glucose monitoring data from the INITIATION study.
    Manski-Nankervis J; Yates CJ; Blackberry I; Furler J; Ginnivan L; Cohen N; Jenkins A; Vasanthakumar S; Gorelik A; Young D; Best J; O'Neal D
    Diabet Med; 2016 Jun; 33(6):803-11. PubMed ID: 26435033
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does serum 1,5-anhydroglucitol establish a relationship between improvements in HbA1c and postprandial glucose excursions? Supportive evidence utilizing the differential effects between biphasic insulin aspart 30 and insulin glargine.
    Moses AC; Raskin P; Khutoryansky N
    Diabet Med; 2008 Feb; 25(2):200-5. PubMed ID: 18290862
    [TBL] [Abstract][Full Text] [Related]  

  • 9. How well do glucose variability measures predict patient glycaemic outcomes during treatment intensification in type 2 diabetes?
    Inzucchi SE; Umpierrez G; DiGenio A; Zhou R; Kovatchev B
    Diabetes Res Clin Pract; 2015 Apr; 108(1):179-86. PubMed ID: 25661664
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glipizide controlled-release tablets, with or without acarbose, improve glycaemic variability in newly diagnosed Type 2 diabetes.
    Bao YQ; Zhou J; Zhou M; Cheng YJ; Lu W; Pan XP; Tang JL; Lu HJ; Jia WP
    Clin Exp Pharmacol Physiol; 2010 May; 37(5-6):564-8. PubMed ID: 20082624
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Continuous Glucose Monitoring and Use of Alternative Markers To Assess Glycemia in Chronic Kidney Disease.
    Zelnick LR; Batacchi ZO; Ahmad I; Dighe A; Little RR; Trence DL; Hirsch IB; de Boer IH
    Diabetes Care; 2020 Oct; 43(10):2379-2387. PubMed ID: 32788282
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glycaemic instability is an underestimated problem in Type II diabetes.
    Praet SF; Manders RJ; Meex RC; Lieverse AG; Stehouwer CD; Kuipers H; Keizer HA; van Loon LJ
    Clin Sci (Lond); 2006 Aug; 111(2):119-26. PubMed ID: 16613586
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glycaemic markers and all-cause mortality in older adults with and without diabetes: the Atherosclerosis Risk in Communities (ARIC) study.
    Rooney MR; Tang O; Pankow JS; Selvin E
    Diabetologia; 2021 Feb; 64(2):339-348. PubMed ID: 32990802
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of glycemic variability in well-controlled type 2 diabetes mellitus.
    Chon S; Lee YJ; Fraterrigo G; Pozzilli P; Choi MC; Kwon MK; Chin SO; Rhee SY; Oh S; Kim YS; Woo JT
    Diabetes Technol Ther; 2013 Jun; 15(6):455-60. PubMed ID: 23617251
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Integrating glycaemic variability in the glycaemic disorders of type 2 diabetes: a move towards a unified glucose tetrad concept.
    Monnier L; Colette C; Owens DR
    Diabetes Metab Res Rev; 2009 Jul; 25(5):393-402. PubMed ID: 19437415
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between serum osteocalcin and glycaemic variability in Type 2 diabetes.
    Bao YQ; Zhou M; Zhou J; Lu W; Gao YC; Pan XP; Tang JL; Lu HJ; Jia WP
    Clin Exp Pharmacol Physiol; 2011 Jan; 38(1):50-4. PubMed ID: 21083700
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glycated albumin but not HbA1c reflects glycaemic control in patients with neonatal diabetes mellitus.
    Suzuki S; Koga M; Amamiya S; Nakao A; Wada K; Okuhara K; Hayano S; Sarhat AR; Takahashi H; Matsuo K; Tanahashi Y; Fujieda K
    Diabetologia; 2011 Sep; 54(9):2247-53. PubMed ID: 21644010
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduction in glycated albumin can predict change in HbA1c: comparison of oral hypoglycaemic agent and insulin treatments.
    Won HK; Kim KJ; Lee BW; Kang ES; Cha BS; Lee HC
    Diabet Med; 2012 Jan; 29(1):74-9. PubMed ID: 21781151
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HbA₁(c) and mean blood glucose show stronger associations with cardiovascular disease risk factors than do postprandial glycaemia or glucose variability in persons with diabetes: the A1C-Derived Average Glucose (ADAG) study.
    Borg R; Kuenen JC; Carstensen B; Zheng H; Nathan DM; Heine RJ; Nerup J; Borch-Johnsen K; Witte DR;
    Diabetologia; 2011 Jan; 54(1):69-72. PubMed ID: 20886203
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of acarbose versus glibenclamide on glycemic excursion and oxidative stress in type 2 diabetic patients inadequately controlled by metformin: a 24-week, randomized, open-label, parallel-group comparison.
    Wang JS; Lin SD; Lee WJ; Su SL; Lee IT; Tu ST; Tseng YH; Lin SY; Sheu WH
    Clin Ther; 2011 Dec; 33(12):1932-42. PubMed ID: 22078152
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.